SEC Form D · Amendment · filed February 1, 2021
Sea Pharmaceuticals, LLC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Shaker J. Sadasivam · Cambridge, MADirectorNabil J. Elkouh · Cambridge, MADirectorEric R. Olson · Cambridge, MADirectorBenjamin J. Cravatt · Cambridge, MADirectorJames P. Pearson · Cambridge, MAExec · DirectorMichael J. Higgins · Cambridge, MADirectorWalter K. Brown · Cambridge, MADirectorMark G. Currie · Cambridge, MADirectorMerrill Kaliser · Dallas, TXDirectorCherry Chen · Dallas, TXDirectorBarbara S. Marshall · New York, NYDirectorSam B. Crigman · CARPINTERIA, CAExec · DirectorJohn Todderud · Renton, WADirectorCathy L. Berry · New York, NYDirectorKathleen S. Marshall Lagambina · New York, NYDirectorKyle D. Miller · Dallas, TXDirectorJames P. Mcconnell · SIMSBURY, CTExec · DirectorMohit Bhatnagar · Walnut, CADirectorEldon Klaassen · New York, NYDirectorPavel Khodorkovskiy · New York, NYDirectorThomas Blum · New York, NYDirectorBob Saris · Brooklyn, NYDirectorSean L. Sauler · New York, NYDirectorAdam L. Bensley · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗